首页> 美国卫生研究院文献>Redox Biology >Ugonin U stimulates NLRP3 inflammasome activation and enhances inflammasome-mediated pathogen clearance
【2h】

Ugonin U stimulates NLRP3 inflammasome activation and enhances inflammasome-mediated pathogen clearance

机译:Ugonin U刺激NLRP3炎性体活化并增强炎性体介导的病原体清除

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The NOD-like receptor pyrin domain 3 (NLRP3) inflammasome contains Nod-like receptors, a subclass of pattern recognition receptors, suggesting that this complex has a prominent role in host defenses. Various structurally diverse stimulators activate the NLRP3 inflammasome through different signaling pathways. We previously reported that ugonin U (UgU), a natural flavonoid isolated from Helminthostachys zeylanica (L) Hook, directly stimulates phospholipase C (PLC) and triggers superoxide release in human neutrophils. In the present study, we showed that UgU induced NLRP3 inflammasome assembly and subsequent caspase-1 and interleukin (IL)-1β processing in lipopolysaccharide-primed human monocytes. Moreover, UgU elicited mitochondrial superoxide generation in a dose-dependent manner, and a specific scavenger of mitochondrial reactive oxygen species (ROS) diminished UgU-induced IL-1β and caspase-1 activation. UgU induced Ca2+ mobilization, which was inhibited by treatment with inhibitors of PLC or inositol triphosphate receptor (IP3R). Blocking Ca2+ mobilization, PLC, or IP3R diminished UgU-induced IL-1β release, caspase-1 activation, and mitochondrial ROS generation. These data demonstrated that UgU activated the NLPR3 inflammasome activation through Ca2+ mobilization and the production of mitochondrial ROS. We also demonstrated that UgU-dependent NLRP3 inflammasome activation enhanced the bactericidal function of human monocytes. The ability of UgU to stimulate human neutrophils and monocytes, both of which are professional phagocytes, and its capacity to activate the NLRP3 inflammasome, which is a promising molecular target for developing anti-infective medicine, indicate that UgU treatment should be considered as a possible novel therapy for treating infectious diseases.
机译:NOD样受体吡啶结构域3(NLRP3)炎性小体包含Nod样受体,这是模式识别受体的一个子类,表明该复合物在宿主防御中具有重要作用。各种结构不同的刺激物通过不同的信号传导途径激活NLRP3炎性体。我们之前曾报道过,ugonin U(UgU)是从Helminthostachys zeylanica(L)Hook中分离出来的天然类黄酮,直接刺激磷脂酶C(PLC)并触发人类嗜中性粒细胞中超氧化物的释放。在本研究中,我们显示了UgU在脂多糖引发的人单核细胞中诱导了NLRP3炎性小体组装以及随后的caspase-1和白介素(IL)-1β加工。此外,UgU以剂量依赖的方式引起线粒体超氧化物的产生,线粒体活性氧(ROS)的特定清除剂减少了UgU诱导的IL-1β和caspase-1活化。 UgU诱导的Ca 2 + 动员,通过PLC抑制剂或三磷酸肌醇受体(IP3R)抑制剂可抑制。阻止Ca 2 + 动员,PLC或IP3R减少了UgU诱导的IL-1β释放,caspase-1激活和线粒体ROS生成。这些数据表明,UgU通过Ca 2 + 动员和线粒体ROS的产生激活了NLPR3炎性体的激活。我们还证明依赖UgU的NLRP3炎性小体激活增强了人类单核细胞的杀菌功能。 UgU刺激均属于专业吞噬细胞的人类嗜中性粒细胞和单核细胞的能力,以及其激活NLRP3炎性小体的能力,NLRP3炎性小体是开发抗感染药物的有希望的分子靶标,表明应考虑将UgU治疗视为可能治疗传染病的新疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号